Cargando…
Predictive value of drug efficacy by M6A modification patterns in rheumatoid arthritis patients
BACKGROUND: Rheumatoid arthritis is a highly heterogeneous autoimmune disease characterized by unpredictable disease flares and significant differences in therapeutic response to available treatments. One possible reason for poor efficacy is that it cannot be treated accurately due to no optimal str...
Autores principales: | Song, Shan, Zhao, Rong, Qiao, Jun, Liu, Jia, Cheng, Ting, Zhang, Sheng-Xiao, Li, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427021/ https://www.ncbi.nlm.nih.gov/pubmed/36052084 http://dx.doi.org/10.3389/fimmu.2022.940918 |
Ejemplares similares
-
N(6)
-Methyladenosine and Rheumatoid Arthritis: A Comprehensive Review
por: Wu, Sha, et al.
Publicado: (2021) -
Diagnostic gene signatures and aberrant pathway activation based on m6A methylation regulators in rheumatoid arthritis
por: Geng, Qishun, et al.
Publicado: (2022) -
Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
por: Lu, XiaoQin, et al.
Publicado: (2021) -
Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis
por: Fan, Junyu, et al.
Publicado: (2023) -
Low-dose IL-2 improved clinical symptoms by restoring reduced regulatory T cells in patients with refractory rheumatoid arthritis: A randomized controlled trial
por: Wang, Jia, et al.
Publicado: (2022)